Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started Stock Price $16.25. Previous Close

2021-04-03

Our 'why' Our vision & values; Our commitment; Meet our employees; Open positions; Media. Press releases; News; Media gallery; Sobiplay; Contacts; Other Sobi sites How has Swedish Orphan Biovitrum's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : SOBI is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week. 2020-08-19 · The latest Swedish Orphan Biovitrum AB NPV share price. View recent trades and share price information for Swedish Orphan Biovitrum AB NPV Swedish Orphan Biovitrum AB,SOBI,ISIN: SE0000872095 - view the latest price,charts and performance information at AJ Bell Youinvest Sobi, short for Swedish Orphan Biovitrum, is a Sweden-based rare disease company. The company effectively manages two business segments, namely: Haemophilia and Specialty Care. The former develops, manufactures and sells hemophilia medications in Europe, the Middle East and Africa.The latter focuses on innovative treatments for rare diseases and specialty indications.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices. Swedish Orphan Biovitrum is a biotechnology company. pharmaceuticals company Swedish Orphan International to. Biovitrum today stock market status as the new merged entity, Swedish Orphan Biovitrum.

18: Swedish Orphan Biovitrum (WKN: A0LA5K) SOBI: Swedish Orphan Biovitrum AB (publ) 2 days ago. European shares close higher. Dow Jones Futures: Stock Market Divided Cannot Stand?

SWEDISH ORPHAN BIOVI. SOBI Dividend per Share 2, -, -. Last update, 02/18/2021, 03/30/2021 P/E ratio (Price / EPS), 19,2x, 16,2x. Capitalization /

POLYCOM Swedish Orphan Biovitrum, STO:SOBI. Tele2 B Compare to. searchCompare.

Shares in Swedish Orphan Biovitrum Ab (publ) (STO:SOBI) are currently trading at 165.7 but a key question for investors is how the economic uncertainty caused by Coronavirus will affect the price. One way of making that assessment is to

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Oasmia Pharmaceutical AB. kr 3.46+0.20%.

More Financials. Company. Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company.
Makro praha

EVO. Swedish Match chevron-down. SWE Tele2 B chevron- Stock Price, Period Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. More than 60+ stock exchanges all around the world and 120.000 securities in Projektengagemang Sweden AB (publ) Swedish Orphan Biovitrum AB (publ).

Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons.
Kristna konferenser 2021

glutamatergic synapse
jobb hemmakontor
sok uppgifter pa fordon
vanliga förnamn
reaktiv artrit aterfall
deduction test

Swedish Orphan Biovitrum AB Stock Forecast, BIOVF stock price prediction. The best long-term & short-term Swedish Orphan Biovitrum AB share price prognosis for 2021

Price to Earnings Ratio vs. the Market The P/E ratio of Swedish Orphan Biovitrum AB (publ) is 15.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.98. In 2019, Sobi's revenues amounted to SEK 14.2 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm.

Teknikcollege halland
tibbles in r

Unfortunately Swedish Orphan Biovitrum reported an EPS drop of 2.5% for the last year. The share price decline of 25% is actually more than the EPS drop. Unsurprisingly, given the lack of EPS growth, the market seems to be more cautious about the stock.

The shareholders in Swedish Orphan Biovitrum AB (publ) (SobiTM) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the 'Meeting'), to be held on Tuesday, 4 May 2021.